Underpowered trials at trial start and informed consent: action is needed beyond the COVID-19 pandemic.
IF 8.8
2区 医学
Q1 MEDICINE, GENERAL & INTERNAL
引用次数: 0
试验开始时力量不足和知情同意：在 COVID-19 大流行之后仍需采取行动。
本文章由计算机程序翻译，如有差异，请以英文原文为准。
求助全文
约1分钟内获得全文
求助全文
来源期刊
CiteScore
8.40
自引率
3.50%
发文量
107
审稿时长
6-12 weeks
期刊介绍：
Since 1809, the Journal of the Royal Society of Medicine (JRSM) has been a trusted source of information in the medical field. Our publication covers a wide range of topics, including evidence-based reviews, original research papers, commentaries, and personal perspectives. As an independent scientific and educational journal, we strive to foster constructive discussions on vital clinical matters. While we are based in the UK, our articles address issues that are globally relevant and of interest to healthcare professionals worldwide.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
